NASDAQ:KRMD KORU Medical Systems Q3 2026 Earnings Date & Estimates $3.10 +0.10 (+3.33%) Closing price 03:59 PM EasternExtended Trading$3.12 +0.02 (+0.48%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. KORU Medical Systems is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 11, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from KORU Medical Systems in Q3 2026KORU Medical Systems is expected to post earnings of -$0.0168 per share on revenue of $11.33 million. KORU Medical Systems last reported on August 5, 2026, posting $0.01 per share and beating the -$0.0180 consensus estimate. KORU Medical Systems has beaten the consensus EPS estimate in 7 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.0168Expected Revenue$11.33 millionRecent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.01 (Beat by +$0.0280)Last Quarter Revenue$12.05 millionEPS Beat Rate7 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ4 2025 Earnings ReportQ2 2025 Earnings Report KORU Medical Systems Q3 2026 Earnings FAQ When does KORU Medical Systems report Q3 2026 earnings? KORU Medical Systems (NASDAQ:KRMD) is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is KORU Medical Systems' Q3 2026 earnings call? KORU Medical Systems' Q3 2026 earnings conference call is scheduled for Wednesday, November 11, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for KORU Medical Systems? Analysts expect KORU Medical Systems to post earnings of -$0.0168 per share for Q3 2026. How much revenue is KORU Medical Systems expected to report? The consensus revenue estimate for KORU Medical Systems is $11.33 million for Q3 2026. KORU Medical Systems Earnings HeadlinesKORU Medical Systems Selloff Offers An OpportunityAugust 22, 2026 | seekingalpha.comKORU (KRMD) Q2 2026 Earnings Call TranscriptAugust 12, 2026 | finance.yahoo.comTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.October 14 at 1:00 AM | Banyan Hill Publishing (Ad)KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call TranscriptAugust 6, 2026 | seekingalpha.comKORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 GuidanceAugust 5, 2026 | businesswire.comKORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth ConferenceJuly 29, 2026 | businesswire.comSee More KORU Medical Systems Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like KORU Medical Systems? Sign up for Earnings360's daily newsletter to receive timely earnings updates on KORU Medical Systems and other key companies, straight to your email. Email Address About KORU Medical SystemsKORU Medical Systems (NASDAQ:KRMD) develops and manufactures portable infusion systems used to deliver specialty pharmaceuticals, biologic therapies and other fluids. The company’s products are designed primarily for subcutaneous infusion, allowing certain treatments to be administered in home-care and ambulatory settings. Its product portfolio includes the Freedom Syringe Infusion System, which comprises ambulatory infusion pumps such as the Freedom60, FreedomEdge and FreedomQ models, along with flow-control tubing sets, needles and related accessories. These systems are commonly used in the administration of subcutaneous immunoglobulin and other therapies for conditions including primary immunodeficiency and certain neurological disorders. Founded in 1980 and headquartered in Milford, Connecticut, KORU serves healthcare providers, specialty pharmacies, home-infusion companies and patients in the United States and international markets through direct sales and distribution partners. The company’s products are intended to support portable, patient-controlled treatment outside traditional hospital settings.View KORU Medical Systems ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Citi Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenIREN Limited's AI Pivot Gains Traction—But Can Its Data Centers Deliver?PBF Energy's Stunning Rally Faces a Critical TestA Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?Albertsons Is Betting on a Turnaround—But Will It Pay Off?PepsiCo's Earnings Beat Masks a Bigger Problem With Its North American Business Upcoming Earnings Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026)U.S. Bancorp (10/15/2026)Prologis (10/15/2026)Taiwan Semiconductor Manufacturing (10/15/2026)Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
